| scholarly article | Q13442814 |
| P50 | author | Napoleone Ferrara | Q1769254 |
| P2093 | author name string | Victoria L. Bautch | |
| Sarah M. Taylor | |||
| John C. Chappell | |||
| P2860 | cites work | Embryonic stem cell differentiation: emergence of a new era in biology and medicine | Q22065783 |
| Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor | Q24320710 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis | Q28588019 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis | Q29614939 | ||
| VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia | Q29617501 | ||
| Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization | Q30579125 | ||
| A membrane associated mCherry fluorescent reporter line for studying vascular remodeling and cardiac function during murine embryonic development | Q33413167 | ||
| Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms | Q34787725 | ||
| The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation | Q35098106 | ||
| The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. | Q35652503 | ||
| Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis | Q35804497 | ||
| Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression | Q36072768 | ||
| Vascular development: from precursor cells to branched arterial and venous networks | Q36133395 | ||
| Endothelial cells and VEGF in vascular development | Q36342350 | ||
| Vascular endothelial growth factor signaling pathways: therapeutic perspective | Q36584934 | ||
| The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. | Q36677542 | ||
| Building blood vessels--stem cell models in vascular biology | Q36834586 | ||
| Regulation of vascular morphogenesis by Notch signaling | Q36972249 | ||
| Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma | Q36995485 | ||
| Multicellular sprouting during vasculogenesis | Q37006676 | ||
| Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis | Q37120111 | ||
| Branching morphogenesis | Q37290816 | ||
| Patterning mechanisms of branched organs | Q37341355 | ||
| VEGF and endothelial guidance in angiogenic sprouting | Q42078015 | ||
| Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. | Q43871279 | ||
| Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. | Q44198738 | ||
| Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. | Q52122639 | ||
| In vitro differentiation of mouse ES cells: hematopoietic and vascular development | Q75209456 | ||
| Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation | Q77885558 | ||
| VEGF receptor signal transduction | Q81931185 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | FMS-like tyrosine kinase 1 | Q21990307 |
| P304 | page(s) | 377–386 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Developmental Cell | Q1524277 |
| P1476 | title | Local guidance of emerging vessel sprouts requires soluble Flt-1 | |
| P478 | volume | 17 |
| Q38049000 | "Sprouting angiogenesis", a reappraisal |
| Q27003730 | A brief overview of preeclampsia |
| Q27324767 | A computational model predicting disruption of blood vessel development |
| Q27003945 | A systems biology view of blood vessel growth and remodelling |
| Q34876665 | Accelerated coronary angiogenesis by vegfr1-knockout endocardial cells |
| Q45065026 | Agent-based computational model of retinal angiogenesis simulates microvascular network morphology as a function of pericyte coverage. |
| Q27334865 | Agent-based model of angiogenesis simulates capillary sprout initiation in multicellular networks |
| Q34080032 | Alternate processing of Flt1 transcripts is directed by conserved cis-elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation. |
| Q27318214 | Angiogenesis in the developing spinal cord: blood vessel exclusion from neural progenitor region is mediated by VEGF and its antagonists |
| Q27324838 | Angiogenesis: an adaptive dynamic biological patterning problem |
| Q36526596 | Angiogenic factors in preeclampsia and related disorders |
| Q30574383 | ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1. |
| Q89995945 | Blood Vessel Patterning on Retinal Astrocytes Requires Endothelial Flt-1 (VEGFR-1) |
| Q38366760 | Blood and lymphatic vessel formation |
| Q48183560 | Blood vessel anastomosis is spatially regulated by Flt1 during angiogenesis. |
| Q36711983 | Characterizing the angiogenic activity of patients with single ventricle physiology and aortopulmonary collateral vessels |
| Q58801489 | Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients |
| Q38918315 | Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study |
| Q39394557 | Circulating free soluble fms-like tyrosine kinase-1 during late first trimester in relation with placental volume as a surrogate for trophoblastic production: a physiology study in low-risk cohort |
| Q38233272 | Collective motion of cells: from experiments to models |
| Q64111799 | Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis |
| Q30430268 | Computational modeling of interacting VEGF and soluble VEGF receptor concentration gradients. |
| Q38430192 | Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis |
| Q34543371 | Design of growth factor sequestering biomaterials |
| Q33786526 | Dynamic alterations in decoy VEGF receptor-1 stability regulate angiogenesis |
| Q41490834 | Dynamic, heterogeneous endothelial Tie2 expression and capillary blood flow during microvascular remodeling |
| Q41937678 | Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice |
| Q38121852 | Endothelial cell motility, coordination and pattern formation during vasculogenesis |
| Q42876374 | Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting |
| Q33970802 | Environmental impact on vascular development predicted by high-throughput screening |
| Q41807001 | Epicardial HIF signaling regulates vascular precursor cell invasion into the myocardium |
| Q34031959 | Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis |
| Q88707167 | Establishment and characterization of an embryonic pericyte cell line |
| Q91604767 | Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation |
| Q33795730 | Extracellular matrix, inflammation, and the angiogenic response |
| Q27000351 | Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. |
| Q30276870 | Flt-1 (VEGFR-1) coordinates discrete stages of blood vessel formation |
| Q42409352 | Flt-1 (vascular endothelial growth factor receptor-1) is essential for the vascular endothelial growth factor-Notch feedback loop during angiogenesis |
| Q30499862 | Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo |
| Q28505995 | Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth |
| Q33912433 | Formation and maturation of the native cerebral collateral circulation |
| Q21202775 | Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis |
| Q39699823 | Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling |
| Q37945438 | How blood vessel networks are made and measured |
| Q34426782 | Human aging and CD31+T-cell number, migration, apoptotic susceptibility, and telomere length |
| Q42155801 | Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing. |
| Q34339378 | Hypoxia influences the vascular expansion and differentiation of embryonic stem cell cultures through the temporal expression of vascular endothelial growth factor receptors in an ARNT-dependent manner |
| Q30411281 | Integration of experimental and computational approaches to sprouting angiogenesis. |
| Q38704738 | Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis. |
| Q55517226 | Live imaging of wound angiogenesis reveals macrophage orchestrated vessel sprouting and regression. |
| Q47958957 | Mechanisms of growth of a pulmonary capillary network in adult lung |
| Q35706308 | Mechanisms of vascular endothelial growth factor-induced pathfinding by endothelial sprouts in biomaterials |
| Q36554547 | MicroRNA control of vascular endothelial growth factor signaling output during vascular development |
| Q36475841 | MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling. |
| Q64103497 | Microvascular bioengineering: a focus on pericytes |
| Q64900966 | Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis. |
| Q37377316 | Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer |
| Q54901493 | Molecular Mechanisms of Preeclampsia. |
| Q50423780 | Molecular Regulation of Sprouting Angiogenesis |
| Q27007664 | Molecular control of endothelial cell behaviour during blood vessel morphogenesis |
| Q30841236 | Motor neurons control blood vessel patterning in the developing spinal cord |
| Q35592822 | Neuronal action on the developing blood vessel pattern |
| Q37584778 | Neuronal sFlt1 and Vegfaa determine venous sprouting and spinal cord vascularization. |
| Q37421707 | Notch regulates BMP responsiveness and lateral branching in vessel networks via SMAD6. |
| Q42554972 | Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway |
| Q51652487 | Parameter estimation with a novel gradient-based optimization method for biological lattice-gas cellular automaton models. |
| Q92421283 | Pericytes in Hereditary Hemorrhagic Telangiectasia |
| Q44205350 | Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. |
| Q52558418 | Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1. |
| Q33419126 | Pre-eclampsia has an adverse impact on maternal and fetal health |
| Q35143007 | Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease |
| Q37230805 | Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist |
| Q38125964 | Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer |
| Q27001612 | Receptor tyrosine kinase-mediated angiogenesis |
| Q35546629 | Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells |
| Q27006807 | Regulation of blood vessel sprouting |
| Q38806703 | Regulation of soluble Flt-1 (VEGFR-1) production by hnRNP D and protein arginine methylation |
| Q38212662 | Roles of VEGF-A signalling in development, regeneration, and tumours |
| Q35445281 | Rspo1/Wnt signaling promotes angiogenesis via Vegfc/Vegfr3 |
| Q24617241 | Semaphorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy receptor sFlt1 |
| Q64991000 | SiRNA silencing of VEGF, IGFs, and their receptors in human retinal microvascular endothelial cells. |
| Q52879699 | Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease. |
| Q51795270 | Study of normal and pathological blood vessel morphogenesis in Flt1-tdsRed BAC Tg mice. |
| Q55078229 | The Janus Face of VEGF in Stroke. |
| Q28473733 | The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound |
| Q38161389 | The dynamics of developmental and tumor angiogenesis-a comparison. |
| Q38082559 | The tip cell concept 10 years after: new players tune in for a common theme |
| Q38841567 | Therapeutic angiogenesis: angiogenic growth factors for ischemic heart disease |
| Q38262905 | Tissue guidance without filopodia. |
| Q37882105 | Tubulogenesis during blood vessel formation |
| Q26995733 | Tumor endothelial cells |
| Q38100593 | Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. |
| Q38219834 | Understanding the role of Notch in osteosarcoma |
| Q38116924 | Understanding vascular development |
| Q37947558 | Ups and downs of guided vessel sprouting: the role of polarity |
| Q27687815 | VEGF signaling inside vascular endothelial cells and beyond |
| Q36186517 | VEGF-directed blood vessel patterning: from cells to organism |
| Q37197494 | VEGFR and type-V RTK activation and signaling |
| Q36788592 | Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism |
| Q38007161 | Vascular development in the zebrafish |
| Q37778482 | Vascular development: genetic mechanisms and links to vascular disease |
| Q33834038 | Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. |
| Q27003400 | Vascular endothelial growth factor-B in physiology and disease |
| Q51738941 | Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch. |
Search more.